SCHEMBL6277140

SCHEMBL6277140

CC=C(CC)Oc1c(O)c2c(OCCO)cccc2oc1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NQO1 P15559 1/20 0.42
▸ CYP2A6 P11509 2/20 0.35
▸ KDM4E B2RXH2 2/20 0.34
▸ MEN1 O00255 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ PABPC1 P11940 1/20 0.34
▸ KMT2A Q03164 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ CREB1 P16220 2/20 0.34
▸ POLB P06746 1/20 0.33
▸ NMT2 O60551 4/20 0.32
▸ NMT1 P30419 4/20 0.32
▸ BCHE P06276 1/20 0.32
▸ ACHE P22303 1/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ RAB9A P51151 1/20 0.32
▸ HSD17B10 Q99714 1/20 0.32
▸ ADRB2 P07550 2/20 0.32
▸ ADRB1 P08588 2/20 0.32
▸ ADRB3 P13945 2/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6270557 0.86 NQO1 (0.41) NQO1KDM4EMAPTKMT2ATDP1
SCHEMBL6276689 0.85 GPR35 (0.40) NQO1KDM4EMEN1MAPTPABPC1
SCHEMBL6274319 0.83 NQO1 (0.47) NQO1CYP2A6KDM4EMEN1MAPT
SCHEMBL6275924 0.83 ADORA3 (0.36) CYP2A6
SCHEMBL6270800 0.82 CYP2A6 (0.47) NQO1CYP2A6KDM4EMEN1MAPT
SCHEMBL6275142 0.82 NQO1 (0.54) NQO1KDM4EMEN1MAPTKMT2A
SCHEMBL6271677 0.82 NQO1 (0.43) NQO1CYP2A6KDM4EMEN1MAPT
SCHEMBL6271675 0.82 NQO1 (0.43) NQO1CYP2A6KDM4EMEN1MAPT
SCHEMBL6274460 0.81 NQO1 (0.45) NQO1CYP2A6CREB1POLH
SCHEMBL6276186 0.81 ALOX5 (0.45) NQO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1273578-B1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK & CHEMICALS (JP) 2005-02-23 — — EP disclosed
US-6670391-B2 For inhibiting both immediate and delayed type allergic reactions; side effect reduction DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-12-30 — — US disclosed
US-20030096860-A1 Benzopyran derivative and antiallergic agent DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-05-22 — — US disclosed
EP-1273578-A1 Benzopyran derivatives and antiallergic agent containing the same DAINIPPON INK AND CHEMICALS, INC. (JP) 2003-01-08 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030096860-A1 Benzopyran derivative and antiallergic agent HRH2, HRH1, HRH4 NQO1 1320/4885CYP2A6 117/4885KDM4E 965/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback